Search

Your search keyword '"Morel, Y."' showing total 648 results

Search Constraints

Start Over You searched for: Author "Morel, Y." Remove constraint Author: "Morel, Y."
648 results on '"Morel, Y."'

Search Results

203. Évaluation de la trousse AMH (anti-mullerienne hormone) de Roche®dans les indications pédiatriques : détermination des valeurs de références chez le garçon

204. Late CF caused by homozygous IVS8-5T CFTR polymorphism.

212. Évaluation des performances d’une nouvelle trousse de dosage de l’hormone anti-Müllerienne (AMH) comparée aux trousses actuelles

213. Réponse insuffisante du cortisol à la stimulation par test au tetracosactide (Synacthen®) chez les patients avec hyperplasie congénitale des surrénales de forme non classique (NCCAH) : une exception à la règle ?

220. Decrease of anti-Mullerian hormone in genetic spermatogenic failure.

221. Influence of bottom topography on an upwelling current: Generation of long trapped filaments

222. Eddies in the Tropical Atlantic Ocean and Their Seasonal Variability.

223. Endocrine and molecular investigations in a cohort of 25 adolescent males with prominent/persistent pubertal gynecomastia.

224. Déficit en aldostérone-synthase : 4 observations pédiatriques

225. Only two mutations detected in 15 Tunisian patients with 11β-hydroxylase deficiency: the p.Q356X and the novel p.G379V.

226. Pseudoexon activation in the PKHD1 gene: a French founder intronic mutation IVS46+653A>G causing severe autosomal recessive polycystic kidney disease.

227. Theory and analysis of acoustic-gravity waves in a free-surface compressible and stratified ocean.

228. Hypoplasie congénitale des surrénales : à propos de quatre observations

229. Haemochromatosis screening in 120 patients complaining with persistant fatigue

230. The virilized female: endocrine background.

232. Piezoelectric-actuated, piezoresistive-sensed circular micromembranes for label-free biosensing applications.

233. SFCP-P06 – Urologie – Le « Y vanishing syndrome » – présentation de 3 cas cliniques

234. Altimetry for the future: Building on 25 years of progress

235. A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma.

236. Development and evaluation of a liquid chromatography-tandem mass spectrometry method for simultaneous measurement of toxic aldehydes from brain tissue.

237. Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123.

238. Utilization of LC-MS/MS and Drift Tube Ion Mobility for Characterizing Intact Oxidized Arachidonate-Containing Glycerophosphatidylethanolamine.

239. Loss of LGR4/GPR48 causes severe neonatal salt wasting due to disrupted WNT signaling altering adrenal zonation.

240. Impact of the Heartfulness program on loneliness in high schoolers: Randomized survey study.

241. Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.

242. Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.

243. Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria.

244. Clinical, biochemical, and biomolecular aspects of congenital adrenal hyperplasia in a group of Cameroonian children and adolescents.

245. Structure-specific, accurate quantitation of plasmalogen glycerophosphoethanolamine.

246. Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control [version 2; peer review: 2 approved].

247. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.

248. Ethical and Social Aspects of Neurorobotics.

249. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.

250. Preoperative Topical Estrogen Treatment vs Placebo in 244 Children With Midshaft and Posterior Hypospadias.

Catalog

Books, media, physical & digital resources